The Nevada Senate has approved a bill that would create a new working group to study psychedelics and develop a plan to allow regulated access for therapeutic purposes, sending it to the Assembly for consideration.
The legislation as introduced would have legalized psilocybin and promoted research into the psychedelic, as well as encouraged studies of MDMA, but it was significantly scaled back in committee before passing on the floor in a 16-4 vote on Monday.
Sen. Rochelle Nguyen’s (D) measure as revised now focuses on forming a Psychedelic Medicines Working Group to examine the use of entheogens “in medicinal, therapeutic, and improved wellness.”
The sponsor had acknowledged that the legislation would likely be amended during an initial committee hearing in March, stating that she would be amenable to changes and primarily wanted to initiate a conversation in the legislature about psychedelics reform.
“This working group will put us in a better position to have information and knowledge gathered to make sure that we are doing what’s best for Nevadans,” Nguyen said on the floor on Monday.
“As many people have heard—they’ve heard from the numerous people that this type of treatment, they have found success in it:
Read full article on Marijuana Moment
